Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-12 4:39 pm Sale | 2024-12-10 | 13D | Invivyd, Inc. IVVD | Polaris Venture Partners V L.P. | 8,094,512 6.800% | -437,188 (-5.12%) | Filing History |
| 2023-02-07 5:05 pm Unchanged | 2022-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Polaris Venture Partners V L.P. | 1,423,772 4.500% | 0 (Unchanged) | Filing History |
| 2022-06-24 4:47 pm Unchanged | 2022-06-22 | 13D | Invivyd, Inc. IVVD | Polaris Venture Partners V L.P. | 8,531,700 7.800% | 0 (Unchanged) | Filing History |
| 2022-04-25 9:41 pm Unchanged | 2022-04-25 | 13D | Invivyd, Inc. IVVD | Polaris Venture Partners V L.P. | 8,531,700 7.800% | 0 (Unchanged) | Filing History |
| 2022-03-30 07:37 am Unchanged | 2022-03-28 | 13D | Invivyd, Inc. IVVD | Polaris Venture Partners V L.P. | 8,531,700 7.700% | 0 (Unchanged) | Filing History |
| 2021-08-20 4:21 pm Purchase | 2021-08-10 | 13D | Invivyd, Inc. IVVD | Polaris Venture Partners V L.P. | 8,531,700 7.700% | 8,531,700 (New Position) | Filing History |
| 2021-02-12 5:15 pm Sale | 2020-12-31 | 13G | Phreesia, Inc. PHR | Polaris Venture Partners V L.P. | 0 0.000% | -3,214,092 (Position Closed) | Filing History |
| 2021-02-12 5:10 pm Purchase | 2020-12-31 | 13G | Lyra Therapeutics, Inc. LYRA | Polaris Venture Partners V L.P. | 1,423,772 11.000% | 1,423,772 (New Position) | Filing History |
| 2020-02-12 4:55 pm Sale | 2019-12-31 | 13G | Kala Pharmaceuticals, Inc. KALA | Polaris Venture Partners V L.P. | 23,945 1.700% | -51,692 (-68.34%) | Filing History |
| 2020-02-12 4:52 pm Purchase | 2019-12-31 | 13G | Phreesia, Inc. PHR | Polaris Venture Partners V L.P. | 3,214,092 9.000% | 3,214,092 (New Position) | Filing History |
| 2020-02-12 4:42 pm Purchase | 2019-12-23 | 13D | Cartesian Therapeutics, Inc. RNAC | Polaris Venture Partners V L.P. | 92,996 3.200% | 333 (+0.36%) | Filing History |
| 2020-02-12 4:34 pm Sale | 2019-12-31 | 13G | Cardlytics, Inc. CDLX | Polaris Venture Partners V L.P. | 9,010 0.000% | -2,543,616 (-99.65%) | Filing History |